Patents by Inventor Yuan-Hon Kiang

Yuan-Hon Kiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOTORASIB FORMULATION
    Publication number: 20240226020
    Abstract: The disclosure provides formulations comprising sotorasib (1), a diluent, a disintegrant and a lubricant.
    Type: Application
    Filed: May 5, 2022
    Publication date: July 11, 2024
    Inventors: Fernando Antonio ALVAREZ-NUNEZ, Jiemin BAO, Sai Prasanth CHAMARTHY, Dominick Paul DAURIO, Naga DUGGIRALA, Brett E. HOUK, Yuan-Hon KIANG, Angela OLSOFSKY, Namita SAWANT
  • OMECAMTIV MECARBIL TABLET
    Publication number: 20230090391
    Abstract: Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core, the film coating comprising a modified-release polymer and a pore former. Also provided is a process for making a tablet formulation and a method of treating cardiovascular conditions, such as heart failure, using the tablet formulation.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 23, 2023
    Inventors: Mingda BI, Yuan-Hon KIANG, Hao LOU
  • CRYSTALLINE FORMS OF (R)-8-CHLORO-1-METHYL- 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE
    Publication number: 20160009654
    Abstract: The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same and uses thereof.
    Type: Application
    Filed: March 2, 2015
    Publication date: January 14, 2016
    Inventors: Rajesh Kumar Agarwal, William L. Betts, III, James A. Henshilwood, Yuan-Hon Kiang, Noah Post
  • Crystalline forms of ()-8-chloro-1-methyl-2,3,4,5-tetrahydro-1-3-benzazepine hydrochloride
    Patent number: 8980881
    Abstract: The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same and uses thereof.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: March 17, 2015
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Rajesh K. Agarwal, William L. Betts, III, James A. Henshilwood, Yuan-Hon Kiang, Noah Post
  • Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1H-3-benzazepine hydrochloride
    Patent number: 8697686
    Abstract: The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same and uses thereof.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: April 15, 2014
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Rajesh K. Agarwal, William L. Betts, III, James A. Henshilwood, Yuan-Hon Kiang, Noah Post
  • CRYSTALLINE FORMS OF (R)-8-CHLORO-1-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE
    Publication number: 20140051684
    Abstract: The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same and uses thereof.
    Type: Application
    Filed: September 14, 2012
    Publication date: February 20, 2014
    Inventors: Rajesh K. Agarwal, William L. Betts, III, James A. Henshilwood, Yuan-Hon Kiang, Noah Post
  • CRYSTALLINE FORMS OF (R)-8-CHLORO-1-METHYL-2,3,4,5-THTRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE
    Publication number: 20120264743
    Abstract: The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same and uses thereof.
    Type: Application
    Filed: March 21, 2012
    Publication date: October 18, 2012
    Inventors: Rajesh K. Agarwal, William L. Betts, III, James A. Henshilwood, Yuan-Hon Kiang, Noah Post
  • Crystalline forms of ()-8-chloro-1-methyl-2,3,4,5-tetrahydro-1-3-benzazepine hydrochloride
    Patent number: 8168624
    Abstract: The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same, preparations, and uses thereof.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: May 1, 2012
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Rajesh K. Agarwal, William L. Betts, III, James A. Henshilwood, Yuan-Hon Kiang, Noah Post
  • Crystalline Forms Of (R)-8-Chloro-1-Methyl-2,3,4,5-Tetrahydro-1H-3-Benzazepine Hydrochloride
    Publication number: 20100004223
    Abstract: The present invention is directed to crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, compositions containing the same, preparations, and uses thereof.
    Type: Application
    Filed: December 20, 2005
    Publication date: January 7, 2010
    Applicant: Arena Phamaceuticals, Inc.
    Inventors: Rajesh K. Agarwal, William l. Betts, James A. Henshilwood, Yuan-Hon Kiang, Noah Post
  • Polymorphs of an androgen receptor modulator
    Patent number: 7365202
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: April 29, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Lushi Tan, Robert S. Meissner, Wenjie Li, James J. Perkins, Aaron S. Cote, Joyce Stellabott, Yuan-Hon Kiang
  • Polymorphs of an androgen receptor modulator
    Publication number: 20070129548
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 7, 2007
    Inventors: Lushi Tan, Robert Meissner, Wenjie Li, James Perkins, Aaron Cote, Joyce Stellabott, Yuan-Hon Kiang